[Form 4] IBEX Ltd Insider Trading Activity

Rhea-AI Filing Summary

IBEX Ltd (IBEX) reporting person Taylor C. Greenwald, Chief Financial Officer, sold 2,295 common shares on 09/19/2025 at $40.7302 per share. The Form 4 shows the sale was required to cover tax withholding for restricted stock units that vested and is not described as a discretionary trade. After the transaction the reporting person beneficially owned 33,561 shares, held directly. The filing was signed by an attorney-in-fact on 09/23/2025. No options, derivative transactions, or other compensatory arrangements are disclosed on this Form 4.

Positive

• Transaction disclosed as tax-withholding related to RSU vesting, indicating non-discretionary sale.

Negative

• Reduction in direct holdings by 2,295 shares, leaving 33,561 shares beneficially owned.

Insights

Financial Analyst

TL;DR: Routine tax-withholding sale by the CFO; transaction appears non-discretionary and limited in size.

The sale of 2,295 shares at $40.7302 was performed to satisfy tax withholding obligations tied to RSU vesting, not as an open-market, discretionary sale. The residual direct holding of 33,561 shares remains; absent information on total outstanding shares or materiality thresholds, this transaction is most likely immaterial to overall ownership concentration or company valuation. No derivative activity or additional compensatory securities are reported.

Corporate Governance Expert

TL;DR: Disclosure meets Section 16 reporting standards; sale is documented as required withholding.

The Form 4 includes the required details: reporting person identity, relationship to issuer (CFO), transaction date, price, amount sold, and post-transaction beneficial ownership. The explicit explanation that the sale was to cover tax withholding supports compliance with insider reporting norms. The filing was executed by an attorney-in-fact with a dated signature, providing the standard procedural record.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Greenwald Taylor C

(Last) (First) (Middle)

C/O IBEX LIMITED

1717 PENNSYLVANIA AVENUE NW, SUITE 825

(Street)

WASHINGTON DC 20006

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
IBEX Ltd [ IBEX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

3. Date of Earliest Transaction (Month/Day/Year)
09/19/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Shares	09/19/2025		S(1)		2,295	D	$40.7302	33,561	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The sales reported on this Form 4 represent shares of Common Stock required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units and do not represent discretionary trades by the Reporting Person.

Remarks:

	Lisa Lenstrohm, Attorney-in-Fact	09/23/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did IBEX insider Taylor C. Greenwald do on 09/19/2025?

The reporting person sold 2,295 common shares at $40.7302 per share on 09/19/2025.

Why were the shares sold according to the Form 4?

The Form 4 states the shares were sold to cover tax withholding obligations arising from the vesting of restricted stock units.

How many IBEX shares does the reporting person own after the sale?

The filing reports 33,561 shares beneficially owned following the transaction, held directly.

Was this sale part of an options or derivative transaction?

No. Table II (derivatives) shows no entries; the reported transaction is a non-derivative sale of common shares.

Who signed the Form 4 and when?

The Form 4 was signed by Lisa Lenstrohm, Attorney-in-Fact on 09/23/2025.